| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
DBV Technologies S.A.
13G/A
Amendment 5
DBVT · 23306J309
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 0% | ||||
| VHCP Co-Investment Holdings II, LLC | 0% | ||||
| VHCP Management II, LLC | 0% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 0% | ||||
| VHCP Co-Investment Holdings III, LLC | 0% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 0% | ||||
| VHCP Management III, LLC | 0% | ||||
| VHCP Management EG, LLC | 0% | ||||
| Nimish Shah | 0% | ||||
| Bong Y. Koh | 0% | ||||
|
DBV Technologies S.A.
13G/A
Amendment 4
DBVT · 23306J309
|
8.2% |
11/14/2025
Event 9/30/2025
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 8.2% | ||||
| VHCP Co-Investment Holdings II, LLC | 8.2% | ||||
| VHCP Management II, LLC | 8.2% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 8.2% | ||||
| VHCP Co-Investment Holdings III, LLC | 8.2% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 8.2% | ||||
| VHCP Management III, LLC | 8.2% | ||||
| VHCP Management EG, LLC | 8.2% | ||||
| Nimish Shah | 8.2% | ||||
| Bong Y. Koh | 8.2% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 7
COGT · 19240Q201
|
4.2% |
8/14/2025
Event 6/30/2025
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 4.2% | ||||
| VHCP Co-Investment Holdings II, LLC | 4.2% | ||||
| VHCP Management II, LLC | 4.2% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 4.2% | ||||
| VHCP Co-Investment Holdings III, LLC | 4.2% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 4.2% | ||||
| VHCP Management III, LLC | 4.2% | ||||
| VHCP Management EG, LLC | 4.2% | ||||
| Nimish Shah | 4.2% | ||||
| Bong Y. Koh | 4.2% | ||||
|
DBV Technologies S.A.
13G/A
Amendment 3
DBVT · 23306J309
|
9.8% |
8/14/2025
Event 6/30/2025
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 9.8% | ||||
| VHCP Co-Investment Holdings II, LLC | 9.8% | ||||
| VHCP Management II, LLC | 9.8% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 9.8% | ||||
| VHCP Co-Investment Holdings III, LLC | 9.8% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 9.8% | ||||
| VHCP Management III, LLC | 9.8% | ||||
| VHCP Management EG, LLC | 9.8% | ||||
| Nimish Shah | 9.8% | ||||
| Bong Y. Koh | 9.8% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 6
COGT · 19240Q201
|
5.8% |
4/11/2025
Event 9/30/2024
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 5.8% | ||||
| VHCP Co-Investment Holdings II, LLC | 5.8% | ||||
| VHCP Management II, LLC | 5.8% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 5.8% | ||||
| VHCP Co-Investment Holdings III, LLC | 5.8% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 5.8% | ||||
| VHCP Management III, LLC | 5.8% | ||||
| VHCP Management EG, LLC | 5.8% | ||||
| Nimish Shah | 5.8% | ||||
| Bong Y Koh | 5.8% | ||||
|
Trevi Therapeutics, Inc.
13G/A
Amendment 4
TRVI · 89532M101
|
1.4% |
2/14/2025
Event 12/31/2024
|
|||
| Venrock Healthcare Capital Partners II, L.P. | 1.4% | ||||
| VHCP Co-Investment Holdings II, LLC | 1.4% | ||||
| VHCP Management II, LLC | 1.4% | ||||
| Venrock Healthcare Capital Partners III, L.P. | 1.4% | ||||
| VHCP Co-Investment Holdings III, LLC | 1.4% | ||||
| Venrock Healthcare Capital Partners EG, L.P. | 1.4% | ||||
| VHCP Management III, LLC | 1.4% | ||||
| VHCP Management EG, LLC | 1.4% | ||||
| Nimish Shah | 1.4% | ||||
| Bong Y Koh | 1.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.